☰

Harriet Gee - Publications

Affiliations: 
2008-2010 University of Oxford, Oxford, United Kingdom 
Tree Info Similar researchers PubMed Report error

14/35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Shen H, Chang C, Ing P, Cook K, McKelvey K, Lai J, Gloss B, Prior V, O'Neill G, Blackburn A, Gee H, Hau E. EXTH-41. IMPROVING THE RADIOSENSITIVITY OF DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) BY TARGETING HYPOXIA AND MITOCHONDRIAL METABOLISM Neuro-Oncology. 23: vi172-vi172. DOI: 10.1093/neuonc/noab196.680  0.301
2020 Dhawan A, Scott J, Sundaresan P, Veness M, Porceddu S, Hau E, Harris AL, Buffa FM, Gee HE. Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer. Scientific Reports. 10: 10226. PMID 32576885 DOI: 10.1038/S41598-020-66983-X  0.359
2020 Shen H, Chang C, Gee H, McKelvey K, O’Neill G, Prior V, Blackburn A, Hau E. DIPG-13. TARGETING HYPOXIA AND MITOCHONDRIA WITH REPURPOSED METABOLIC DRUGS AS AN APPROACH TO RADIOSENSITIZATION FOR DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG) Neuro-Oncology. 22: iii289-iii289. DOI: 10.1093/neuonc/noaa222.063  0.329
2018 Dhawan A, Scott J, Sundaresan P, Veness M, Porceddu S, Hau E, Ahern V, Harris A, Buffa F, Gee H. Are Signatures of Radiosensitivity Ready for Routine Clinical Use? a Pragmatic Comparison of Clinical, Pathological and Gene Signature Predictors of Outcome in Oropharynx Head and Neck Cancers International Journal of Radiation Oncology*Biology*Physics. 102: S137-S138. DOI: 10.1016/j.ijrobp.2018.06.338  0.335
2018 Dhawan A, Scott JG, Sundaresan P, Veness M, Porceddu S, Hau E, Ahern V, Harris AL, Buffa FM, Gee HE. Are signatures of radiosensitivity ready for routine clinical use? A pragmatic comparison of clinical, pathological, and gene signature predictors of outcome in oropharynx head and neck cancers. Journal of Clinical Oncology. 36: e18046-e18046. DOI: 10.1016/J.Ijrobp.2018.06.338  0.335
2017 Pajic M, Froio D, Daly S, Doculara L, Millar E, Graham PH, Drury A, Steinmann A, de Bock CE, Boulghourjian A, Zaratzian A, Carroll S, Toohey J, O'Toole SA, Harris AL, ... ... Gee HE, et al. miR-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense. Cancer Research. PMID 29180477 DOI: 10.1158/0008-5472.CAN-16-3105  0.582
2015 Zhang X, Gee H, Rose B, Lee CS, Clark J, Elliott M, Gamble JR, Cairns MJ, Harris A, Khoury S, Tran N. Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in oropharyngeal cancers. Bmc Cancer. 16: 86. PMID 26867589 DOI: 10.1186/s12885-016-2109-4  0.549
2015 Gee HE, Buffa FM, Harris AL, Toohey JM, Carroll SL, Cooper CL, Beith J, McNeil C, Carmalt H, Mak C, Warrier S, Holliday A, Selinger C, Beckers R, Kennedy C, et al. MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer. International Journal of Radiation Oncology, Biology, Physics. 93: 1104-14. PMID 26581147 DOI: 10.1016/j.ijrobp.2015.08.046  0.409
2013 Kumar K, Wigfield S, Gee HE, Devlin CM, Singleton D, Li JL, Buffa F, Huffman M, Sinn AL, Silver J, Turley H, Leek R, Harris AL, Ivan M. Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts. Journal of Molecular Medicine (Berlin, Germany). 91: 749-58. PMID 23361368 DOI: 10.1007/s00109-013-0996-2  0.559
2011 Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Research. 71: 5635-45. PMID 21737487 DOI: 10.1158/0008-5472.CAN-11-0489  0.74
2011 Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, West C, Ragoussis J, Harris AL. The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. British Journal of Cancer. 104: 1168-77. PMID 21407217 DOI: 10.1038/sj.bjc.6606076  0.494
2010 Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, Vojnovic B, Pires das Neves R, Glazer P, Iborra F, Ivan M, et al. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. Plos One. 5: e10345. PMID 20436681 DOI: 10.1371/Journal.Pone.0010345  0.552
2010 Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, Ragoussis J, Harris AL. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer. 116: 2148-58. PMID 20187102 DOI: 10.1002/cncr.25009  0.738
2008 Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, Gleadle JM, Ragoussis J, Harris AL. MicroRNA-10b and breast cancer metastasis. Nature. 455: E8-9; author reply E. PMID 18948893 DOI: 10.1038/nature07362  0.393
Low-probability matches (unlikely to be authored by this person)
2021 Cook KM, Shen H, McKelvey KJ, Gee HE, Hau E. Targeting Glucose Metabolism of Cancer Cells with Dichloroacetate to Radiosensitize High-Grade Gliomas. International Journal of Molecular Sciences. 22. PMID 34298883 DOI: 10.3390/ijms22147265  0.265
2019 Lamichhane SR, Thachil T, Gee H, Milic N. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis. Disease Markers. 2019: 8632018. PMID 31827646 DOI: 10.1155/2019/8632018  0.262
2020 Shen H, Cook K, Gee HE, Hau E. Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas. Journal of Experimental & Clinical Cancer Research : Cr. 39: 129. PMID 32631383 DOI: 10.1186/S13046-020-01639-2  0.258
2014 Gee HE, Ivan C, Calin GA, Ivan M. HypoxamiRs and cancer: From biology to targeted therapy Antioxidants and Redox Signaling. 21: 1220-1238. PMID 24111776 DOI: 10.1089/ars.2013.5639  0.251
2015 Beckers RK, Selinger CI, Vilain R, Madore J, Wilmott JS, Harvey K, Holliday A, Cooper CL, Robbins E, Gillett D, Kennedy CW, Gluch L, Carmalt H, Mak C, Warrier S, ... Gee HE, et al. PDL1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome. Histopathology. PMID 26588661 DOI: 10.1111/his.12904  0.247
2018 Lamichhane SR, Thachil T, De Ieso P, Gee H, Moss SA, Milic N. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Disease Markers. 2018: 8309015. PMID 30538784 DOI: 10.1155/2018/8309015  0.239
2022 Czajkowski D, Szmyd R, Gee HE. Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy. Journal of Medical Imaging and Radiation Oncology. PMID 35460184 DOI: 10.1111/1754-9485.13413  0.191
2016 Beckers RK, Selinger C, Vilain R, Madore J, Wilmott JS, Harvey K, Holliday A, Cooper CL, Robbins E, Gillet D, Kennedy CW, Gluch L, Carmalt H, Mak C, Warrier S, ... Gee HE, et al. PDl1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome. Pathology. 48: S146-S147. PMID 27772919 DOI: 10.1016/j.pathol.2015.12.399  0.183
2020 Sia J, Szmyd R, Hau E, Gee HE. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer. Frontiers in Cell and Developmental Biology. 8: 41. PMID 32117972 DOI: 10.3389/fcell.2020.00041  0.175
2023 Gensheimer MF, Gee H, Shirato H, Taguchi H, Snyder JM, Chin AL, Vitzthum LK, Maxim PG, Wakelee HA, Neal J, Das M, Chang DT, Kidd E, Hancock SL, Shultz DB, et al. Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial. Jama Oncology. PMID 37707820 DOI: 10.1001/jamaoncol.2023.3495  0.17
2021 Gensheimer MF, Gee HE, Von Eyben R, Shirato H, Taguchi H, Wong S, Brown E, Nguyen N, Liang R, Maxim PG, Wakelee HA, Neal JW, Das M, Loo BW, Diehn M. A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR). International Journal of Radiation Oncology, Biology, Physics. 111: S89-S90. PMID 34700657 DOI: 10.1016/j.ijrobp.2021.07.212  0.149
2020 Di Re AM, Sun Y, Sundaresan P, Hau E, Toh JWT, Gee H, Or M, Haworth A. MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: a systematic review. Expert Review of Anticancer Therapy. PMID 33289435 DOI: 10.1080/14737140.2021.1860762  0.147
2018 Gee HE, Moses L, Stuart K, Nahar N, Tiver K, Wang T, Ward R, Ahern V. Contouring consensus guidelines in breast cancer radiotherapy: Comparison and systematic review of patterns of failure. Journal of Medical Imaging and Radiation Oncology. PMID 30267561 DOI: 10.1111/1754-9485.12804  0.124
2023 Boys E, Gao B, Hui R, da Silva I, Hau E, Gee H, Nagrial A. Use of durvalumab in stage III non-small-cell lung cancer based on eligibility for the PACIFIC study. Thoracic Cancer. PMID 36627112 DOI: 10.1111/1759-7714.14780  0.12
2021 Hau E, Lim R, Vinod S, Nahar N, Gee H, Pinkham MB. Radiation therapy in the prevention and management of brain metastases in patients with small cell lung cancer: a narrative review. Chinese Clinical Oncology. PMID 34775779 DOI: 10.21037/cco-21-108  0.111
2015 Gee HE, Bignell F, Odgers D, Gill S, Martin D, Toohey J, Carroll S. In vivo dosimetric impact of breast tissue expanders on post-mastectomy radiotherapy. Journal of Medical Imaging and Radiation Oncology. PMID 26503758 DOI: 10.1111/1754-9485.12403  0.107
2021 Lee K, Le T, Hau E, Hanna GG, Gee H, Vinod S, Dammak S, Palma D, Ong A, Yeghiaian-Alvandi R, Buck J, Lim R. A systematic review into the radiological features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC): Local recurrence features of NSCLC post-SABR. International Journal of Radiation Oncology, Biology, Physics. PMID 34879247 DOI: 10.1016/j.ijrobp.2021.11.027  0.095
2021 Khalil AA, Hau E, Gebski V, Grau C, Gee H, Nyeng TB, West K, Kramer S, Farlow D, Knap M, Møller DS, Hoffmann L, Farr KP. Personal innovative approach in radiation therapy of lung cancer- functional lung avoidance SPECT-guided (ASPECT) radiation therapy: a study protocol for phase II randomised double-blind clinical trial. Bmc Cancer. 21: 940. PMID 34418994 DOI: 10.1186/s12885-021-08663-1  0.09
2019 Shen H, Chang C, Gee H, O’Neill G, Prior V, Blackburn A, Hau E. DIPG-17. IMPROVING THE RADIOSENSITIVITY OF DIFFUSE INTRINSIC PONTINE GLIOMAS BY MODULATING BIOENERGETIC PATHWAYS Neuro-Oncology. 21: ii72-ii72. DOI: 10.1093/NEUONC/NOZ036.038  0.089
2023 Ahn J, Yeghiaian-Alvandi R, Hegi-Johnson F, Browne LH, Graham PH, Chin Y, Gee H, Vinod S, Ludbrook J, Last A, Dwyer P, Ong A, Aherne N, Azzi M, Hau E. Stereotactic Ablative Body Radiotherapy for Early NSCLC: Changes in Pulmonary Function, Dyspnoea and Quality of Life. International Journal of Radiation Oncology, Biology, Physics. PMID 37482136 DOI: 10.1016/j.ijrobp.2023.07.017  0.066
2018 Gee HE, Veness MJ. High-Risk Cutaneous Squamous Cell Carcinoma Current Otorhinolaryngology Reports. 6: 120-128. DOI: 10.1007/s40136-018-0194-4  0.042
Hide low-probability matches.